Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spain raises stem cell profile with infarction trial:

This article was originally published in Clinica

Executive Summary

Spain is preparing to launch a trial on the use of stem cells in repairing heart tissue damaged by infarction. So announced health minister Ana Pastor, during the official launch of the book Messenchymal stem cells: biology and potential clinical uses, in Alicante, on June 9. The event sought to raise the profile of stem cell technology and the need for more research in this field. The Spanish programme to promote R&D co-operation - Redes Tematicas de Investigacion Cooperativa - has a budget of E10.5m ($12.5m) in its first year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT062599

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel